HIGH THROUGHPUT SCREENING - An Exclusive Market Insight Report from RI Technologies

Global HTS market growth is especially driven by the advancements in HTS technologies and the increasing usage of innovative techniques such as Bioinformatics and Lab-on-a-Chip/Microfluidics.

Hyderabad, India (prHWY.com) January 2, 2012 - November 8, 2011 - RI Technologies' (http://www.researchimpact.com) report on High Throughput Screening (HTS) emphasizes on both the technology and product segments of HTS in biotechnology and pharmaceutical application areas. The major technologies analyzed include Ultra High Throughput Screening, High Content/Cell Based Screening, Bioinformatics and Microfluidics/Lab-On-a-Chip; and the major product segments encompass HTS Services and HTS Tools. The global markets for Novel High Throughput Screening Products and Cell Based Assays are also discussed in the report. Markets covered for Microfluidics and Bioinformatics pertain to the applications of HTS. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. The report lists more than 500 companies that are engaged in HTS services and/or production of HTS tools/instruments. Major Contract Research Organizations serving HTS industry are also covered in the corporate directory section of this report. Estimations and predictions are graphically represented by region, by technology and by product segment. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific and Rest of World. The market is analyzed in US Dollars and includes 173 exclusive exhibits.

Global HTS market growth is especially driven by the advancements in HTS technologies and the increasing usage of innovative techniques such as Bioinformatics and Lab-on-a-Chip/Microfluidics. The success of Human Genome Project and latest findings in genomics and proteomics are creating an enormous market for HTS by identifying huge number of drug targets. Currently, automation in HTS industry is in high gear. The companies are investing heavily in laboratory automation products such as HTS software, database systems, robotics arms and robot based workstations.

Strategic partnerships between pharmaceutical and biotechnology companies are the order of the day, and the trend is increasing globally. Another significant trend is the alliances between Pharma and Biotech companies and information technology companies such as Microsoft, IBM, Oracle, Sun, and Infosys, etc. The computer platforms generated by such companies help in managing and analyzing the huge amounts of data produced through High Throughput Screening (HTS) and other computational techniques. Effective R&D strategy involves efficient data management and implementation plans. The new technologies promise improved efficacy, decreased toxicity in patients, and reduced time frames and expenditures. Changing business paradigms brought in by globalization and liberalization are making pharmaceutical companies change strategies for sustenance and growth. Many companies are venturing into HTS studies instead of going for alliances, to become self sufficient and reduce costs. The R&D wings are increasingly becoming target oriented to face the numerous challenges posed in the drug discovery and development industry. High Throughput Screening report is an ideal research tool providing strategic business intelligence to the corporate sector.

About RI Technologies

RI Technologies, established in 2006, is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles, corporate directory and patents information. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. The company's reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. The strategic market information tables, graphically represented, will aid companies' research needs and help in forecasting, and gearing up to the future. Emphasis is on factual insights and forecasts with maximum global coverage. The company strives to provide market insight reports that empower customers with enlightening critical business information.

###

Tag Words: healthcare market size, stem cell research

Categories: Biotech

Press Release Contact
http://researchimpact.com/Mir002.aspx
RI Technologies offers
Email: contactus@researchimpact.com / Phone: +91 9676994272

Link To This Press Release:

URL HTML Code